Inbar Blech completed her B.Sc. in Biology-Psychology with an emphasis on Neuroscience at the Sagol School of Neuroscience at Tel Aviv University. During her studies, Inbar performed a project in our lab, studying the use of antisense oligonucleotides as gene therapy treatment for Congenital Central Hypoventilation Syndrome. Inbar is now performing an M.Sc. in our lab, in the computational program of the Sagol School of Neuroscience. Her project focuses on using bioinformatic and computational techniques to analyze protein structure, function and interactions and develop classification models in order to determine the pathogenicity of variants based on genetic data.